Clinical outcomes of primary stenting for acute coronary syndrome based on selective use of sirolimus-eluting stents

Japanese Journal of Interventional Cardiology

Volumn 24, Issue 1, 2009, Pages 13-20

  Horibe, Hideki ^a   Kawamura, Shotaro ^a   Kodama, Noriko ^a   Nakagawa, Kaori ^a   Murata, Yoshihiro ^a   Kawai, Hideki ^a   Shimizu, Yuhki ^a   Koyasu, Masayoshi ^a   Takemoto, Kenji ^a   Nonogawa, Makoto ^a   Watarai, Masato ^a  

^a ANJO KOSEI HOSPITAL   (Japan)

Author keywords

ACS; PCI; SES

Indexed keywords

METAL; RAPAMYCIN;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RECURRENT DISEASE; REVASCULARIZATION; STENT THROMBOSIS; TIME; TREATMENT OUTCOME;

EID: 62549093185     PISSN: 09148922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Nakagawa G, et al: Clinical and angiographic outcomes of sirolimus-eluting stents implantation in Japanese patients in daily practice. Circ J 70: 1367-1371, 2006.
2. Spaulding C, et al: Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355: 1093-1104, 2006.
3. Laarman GJ, et al: Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 355:1105-13, 2006.
4. Serruys PW, et al: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489-495, 1994.
5. Fischman DL, et al 'A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496-501, 1994.
6. Ellis SG, et al: Real-world bare metal stenting: Identification of patients at low or very low risk of 9-month coronary revascularization. Catheter Cardiovasc Interv 63: 135-140, 2004.
7. Kastrati A, et al: Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30: 1428-1436, 1997.
8. Bauters C, et al: Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 31: 1291-1298, 1998.
9. Cutlip DE, et al: Clinical end points in coronary stent trials. A case for standardized definitions. Circulation 115: 2344- 2351, 2007.
10. Kastrati A, et al: Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 1030-1039, 2007.
11. Stone GW, et al: Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346: 957-966, 2002.
12. Cox DA, et al: Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction. Am J Cardiol 98: 331-337, 2006.
13. Schiele F, et al: Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate;A multicen-ter, randomized study comparing two strategies-with or without intravascular sound guidance. J Am Coll Cardiol32: 320-328, 1998.
14. Mintz GS, et al: Intravascular ultrasound in the drug-eluting stent era. J Am Coll Cardiol 48 421-429, 2006.
15. Steinberg DH, et al: Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (≥3.5 mm) coronary arteries. Am J Cardiol 99:599-602, 2007.
16. Kastrati A, et al: Predictive factors of restenosis after coronary implantation of sirolimus-or paclitaxel-eluting stents. Circulation 113: 2293-2300, 2006.
17. Cutlip DE, et al: Stent thrombosis in the modern era. A pooled analysis of multicenter coronary stent clinical trials. Circularion 103: 1967-1971, 2001.
18. Taniuch M, et al: Randomized comparison of ticlopidine and clopidgrel after intracoronary stent implantation in a broad patient population. Circulation 104: 539-543, 2001.
19. Orford JL, et al: Frequency and correlates of coronary stent thrombosis in the modern era: Analysis of a single center registry. J Am Coll Cardiol 40: 1567-1572, 2002.
20. Mueller C, et al: A randomized comparison of clopidgrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents. J Am Coll Cardiol 41: 969-973, 2003.
21. Heller LI, et al: Late stent thrombosis in the absence of prior intracoronary brachytherapy. Cathet Cardiovasc Intervent S3: 23-28, 2001.
22. Wang F, et al: Late coronary stent thrombosis: Early vs. late stent thrombosis in the stent era. Cathet Cardiovasc Intervent 55: 142-147, 2002.
23. Doyle B, et al: Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 116: 2391-2398, 2007.
24. Spaulding C, et al: A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356: 989-997, 2007.
25. Mehta SR, et al: Effect of pretreatment with clopidgrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention:the PCI-CURE study. Lancet 358: 527-533, 2001.
26. Stone GW, et al: Safety and efficacy of sirolimus-and pacli-taxel-eluting stents. N Engl J Med 356: 998-1008, 2007.